InMed Pharmaceuticals Inc.
General ticker "INM" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $26.6M (TTM average)
InMed Pharmaceuticals Inc. does not follow the US Stock Market performance with the rate: -10.5%.
Estimated limits based on current volatility of 3.9%: low 1.26$, high 1.36$
Factors to consider:
- Total employees count: 12 as of 2021
- Top business risk factors: Product development risks, Regulatory and compliance, Market volatility, Economic downturns and volatility, Supply chain disruptions
- Current price 28.6% below estimated low
- Earnings for 15 months up through Q1 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-06-30 to 2026-06-30
- 2024-06-30 to 2025-06-30 estimated range: [2.49$, 7.83$]
- 2025-06-30 to 2026-06-30 estimated range: [1.88$, 5.95$]
Financial Metrics affecting the INM estimates:
- Positive: with PPE of -0.2 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -355.52 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
- Negative: Industry earnings per price (median), % of -21.29 <= 0
- Positive: Shareholder equity ratio, % of 77.87 > 63.39
- Positive: Investing cash flow per share per price, % of -0.47 > -0.66
- Negative: negative Industry operating income (median)
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term INM quotes
Long-term INM plot with estimates
Financial data
| YTD | 2022-06-30 | 2023-06-30 | 2024-06-30 |
|---|---|---|---|
| Operating Revenue | $1.07MM | $4.14MM | $4.60MM |
| Operating Expenses | $19.67MM | $12.51MM | $12.73MM |
| Operating Income | $-18.60MM | $-8.38MM | $-8.13MM |
| Non-Operating Income | $0.00MM | $0.44MM | $0.47MM |
| R&D Expense | $7.28MM | $3.73MM | $3.22MM |
| Income(Loss) | $-18.60MM | $-7.93MM | $-7.67MM |
| Taxes | $0.00MM | $0.01MM | $0.01MM |
| Profit(Loss)* | $-18.60MM | $-7.95MM | $-7.68MM |
| Stockholders Equity | $9.08MM | $12.09MM | $9.21MM |
| Inventory | $3.21MM | $1.62MM | $1.24MM |
| Assets | $12.79MM | $14.11MM | $11.82MM |
| Operating Cash Flow | $-15.58MM | $-7.28MM | $-6.99MM |
| Capital expenditure | $0.04MM | $0.16MM | $0.01MM |
| Investing Cash Flow | $-0.67MM | $-0.66MM | $-0.01MM |
| Financing Cash Flow | $15.07MM | $10.68MM | $4.65MM |
| Earnings Per Share** | $-16,592.43 | $-64.92 | $-20.14 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.